Skip to main content
The Patent Truth About Health, Innovation and Access
Heer Pardesi, who is 42 years old, holds her antiretroviral drugs for HIV. (Jonas Gratzer/LightRocket via Getty Images)

The Patent Truth About Health, Innovation and Access

Carol Adelman

View PDF

This report reviews and analyzes the following premises of the U.N.‘s High Level Panel on Access to Medicines, which are:

  1. Millions of poor people in low- and middle-income countries have been denied access to antiretroviral drugs and other medicines;
  2. Patents are the main cause of higher costs of medicines for poor people in low- and middle-income countries;
  3. The intellectual property system, including patents and voluntary licenses, limits research and disadvantages local producers in low- and middle- income countries.

These basic assumptions, drawing from the earlier Global Commission on HIV and the Law and the new High Level Panel on Access to Medicines, however, are not supported by global health research.

View PDF

Related Articles

Stripping Intellectual Property Rights from COVID-19 Vaccines Is Disastrous

Adam Mossoff

The Covid-19 pandemic grinds on with the Delta variant dashing hopes of a return to normalcy this fall. Throughout, politicians and activists have mad...

Continue Reading

The Value of Cellular Technology

Urška Petrovčič & Kirti Gupta

Cellular technologies, such as those embodied in the third generation (3G), fourth generation (4G), and fifth generation (5G) of cellular standards, h...

Continue Reading

Special Investigation: What Really Happened in Wuhan

David Asher et al.

This Sky News Australia special investigation into the origins of COVID-19 reveals what really happened in Wuhan in the early days of the pandemic. ...

Watch Now